Designing & Implementing a Robust Late-Clinical Stage Regulatory Action Plan

Time: 11:45 am
day: Day 2 REGULATORY AM

Details:

• Reflecting on lessons learned preparing for and undertaking a BLA/MAA filing
• Top tips for data demonstration earlier in clinical development to support a marketing application
• Facilitating smooth translation of your therapy into a commercial-ready product

Speakers:

Jim Wang Senior regulatory professional with more than 20 years of global experience managing full spectrum drug development, marketing applications, and regulatory approvals, including the approval of Read more